• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同人类血细胞中氨肽酶的类型及定位

Types and localization of aminopeptidases in different human blood cells.

作者信息

Grdisa M, Vitale L

机构信息

Department of Organic Chemistry and Biochemistry, University of Zagreb, Yugoslavia.

出版信息

Int J Biochem. 1991;23(3):339-45. doi: 10.1016/0020-711x(91)90116-5.

DOI:10.1016/0020-711x(91)90116-5
PMID:2044841
Abstract
  1. Erythrocytes, polymorphonuclears, monocytes and lymphocytes isolated from human peripheral blood, were shown to possess in their cytosols, granules and microsomal fractions, aminopeptidases capable of hydrolysing arginyl-, leucyl-, methionyl-, phenylalanyl- and alanyl-2-naphthylamide. 2. In different cell compartments enzymes of different pI were responsible for these activities. 3. Chloride activated arginine aminopeptidase, broad specificity aminopeptidase and dipeptidyl peptidase III were found in cytosols of all examined cells. 4. In granules at least two aminopeptidases, a basic or neutral one, and an acidic one inactive at pH 4.4, could be discerned, whereas in microsomal fractions a broad specificity aminopeptidase preferring methionine was detected. 5. There is a considerable degree of similarity in the pattern of aminopeptidases within different blood cells. This may suggest that their functions are correlated to the physiological role of a particular cell compartment, rather than to that of a distinct cell type.
摘要
  1. 从人外周血中分离出的红细胞、多形核细胞、单核细胞和淋巴细胞,其胞质溶胶、颗粒和微粒体部分均显示含有能够水解精氨酰 -、亮氨酰 -、甲硫氨酰 -、苯丙氨酰 - 和丙氨酰 - 2 - 萘酰胺的氨肽酶。2. 在不同的细胞区室中,不同pI的酶负责这些活性。3. 在所有检测细胞的胞质溶胶中均发现了氯化物激活的精氨酸氨肽酶、广谱特异性氨肽酶和二肽基肽酶III。4. 在颗粒中至少可识别出两种氨肽酶,一种碱性或中性的,以及一种在pH 4.4时无活性的酸性氨肽酶,而在微粒体部分检测到一种偏好甲硫氨酸的广谱特异性氨肽酶。5. 不同血细胞内氨肽酶的模式存在相当程度的相似性。这可能表明它们的功能与特定细胞区室的生理作用相关,而非与特定细胞类型的生理作用相关。

相似文献

1
Types and localization of aminopeptidases in different human blood cells.不同人类血细胞中氨肽酶的类型及定位
Int J Biochem. 1991;23(3):339-45. doi: 10.1016/0020-711x(91)90116-5.
2
Human polymorphonuclear leukocytes aminopeptidases.人类多形核白细胞氨肽酶
Folia Histochem Cytobiol. 1986;24(2):139-48.
3
Properties and distribution of aminopeptidase and dipeptidyl aminopeptidase III of human erythrocytes.人红细胞氨基肽酶和二肽基氨基肽酶III的性质与分布
Acta Biol Med Ger. 1981;40(10-11):1489-95.
4
Aminopeptidase P and dipeptidyl peptidase IV activity in human leukocytes and in stimulated lymphocytes.
Clin Chim Acta. 1991 Feb 15;196(2-3):87-96. doi: 10.1016/0009-8981(91)90061-g.
5
Aminopeptidase B-like enzymes in leukocytes.白细胞中的氨肽酶B样酶。
FEBS Lett. 1977 Apr 15;76(2):219-25. doi: 10.1016/0014-5793(77)80156-7.
6
Decay of proteinase and peptidase activities of human and rabbit erythrocytes during cellular aging.细胞衰老过程中人和兔红细胞蛋白酶及肽酶活性的衰减。
Biochim Biophys Acta. 1981 Jun 11;675(1):110-6. doi: 10.1016/0304-4165(81)90075-1.
7
New chloride-activated aminopeptidase from human erythrocytes.来自人红细胞的新型氯化物激活氨基肽酶。
FEBS Lett. 1989 Aug 14;253(1-2):79-82. doi: 10.1016/0014-5793(89)80934-2.
8
Basic amino acids preferring broad specificity aminopeptidase from human erythrocytes.人红细胞中偏好碱性氨基酸的广谱特异性氨肽酶
Biol Chem Hoppe Seyler. 1992 Jul;373(7):375-80. doi: 10.1515/bchm3.1992.373.2.375.
9
Properties and activities of aminopeptidases in normal and mitogen-stimulated human lymphocytes.正常及丝裂原刺激的人淋巴细胞中氨肽酶的特性与活性
Biochem J. 1985 Feb 15;226(1):59-65. doi: 10.1042/bj2260059.
10
[Alanine and leucine aminopeptidase in isolated human blood cells].
Z Gesamte Inn Med. 1973 Oct 1;28(19):573-6.

引用本文的文献

1
Multidimensional Evaluation of Lisdexamfetamine: Pharmacology, Therapeutic Use, Toxicity and Forensic Implications.赖氨酸安非他明的多维评估:药理学、治疗用途、毒性及法医学意义
Basic Clin Pharmacol Toxicol. 2025 Nov;137(5):e70111. doi: 10.1111/bcpt.70111.
2
Bio-Adrenomedullin and Dipeptidyl Peptidase 3 as Novel Sepsis Biomarkers in the Emergency Department and the Intensive Care Unit: A Narrative Review.生物肾上腺髓质素和二肽基肽酶3作为急诊科和重症监护病房新型脓毒症生物标志物的叙述性综述
Medicina (Kaunas). 2025 Jun 9;61(6):1059. doi: 10.3390/medicina61061059.
3
DPP3: From biomarker to therapeutic target of cardiovascular diseases.
二肽基肽酶3:从生物标志物到心血管疾病的治疗靶点
Front Cardiovasc Med. 2022 Oct 12;9:974035. doi: 10.3389/fcvm.2022.974035. eCollection 2022.
4
Promotion of vascular integrity in sepsis through modulation of bioactive adrenomedullin and dipeptidyl peptidase 3.通过调节生物活性肾上腺髓质素和二肽基肽酶 3 促进脓毒症血管完整性。
J Intern Med. 2021 Jun;289(6):792-806. doi: 10.1111/joim.13220. Epub 2020 Dec 30.
5
Absence of Dipeptidyl Peptidase 3 Increases Oxidative Stress and Causes Bone Loss.二肽基肽酶 3 缺失增加氧化应激并导致骨丢失。
J Bone Miner Res. 2019 Nov;34(11):2133-2148. doi: 10.1002/jbmr.3829. Epub 2019 Sep 9.
6
Purification, kinetic and functional characterization of membrane bound dipeptidyl peptidase-III from NCDC 252: a probiotic lactic acid bacteria.来自益生菌乳酸菌NCDC 252的膜结合二肽基肽酶III的纯化、动力学及功能特性研究
Mol Biol Rep. 2018 Oct;45(5):973-986. doi: 10.1007/s11033-018-4245-1. Epub 2018 Jul 23.
7
Multicohort analysis reveals baseline transcriptional predictors of influenza vaccination responses.多队列分析揭示了流感疫苗接种反应的基线转录预测指标。
Sci Immunol. 2017 Aug 25;2(14). doi: 10.1126/sciimmunol.aal4656.
8
Lisdexamfetamine prodrug activation by peptidase-mediated hydrolysis in the cytosol of red blood cells.赖右苯丙胺前药在红细胞胞质溶胶中通过肽酶介导的水解作用实现激活。
Neuropsychiatr Dis Treat. 2014 Nov 28;10:2275-80. doi: 10.2147/NDT.S70382. eCollection 2014.
9
Neutral endopeptidase activity is not elevated in serum in children with cholestatic liver disease: a unique role of aminopeptidase-m in sequential hydrolysis of peptides.胆汁淤积性肝病患儿血清中的中性内肽酶活性未升高:氨肽酶 - m在肽的顺序水解中的独特作用
Dig Dis Sci. 2002 Aug;47(8):1766-74. doi: 10.1023/a:1016440511089.
10
The aminopeptidase activity in the human T-cell lymphoma line (Jurkat) is not at the cell surface and is not aminopeptidase N (CD-13).人T细胞淋巴瘤细胞系(Jurkat)中的氨肽酶活性不在细胞表面,且不是氨肽酶N(CD-13)。
Biochem J. 1994 Mar 1;298 ( Pt 2)(Pt 2):353-60. doi: 10.1042/bj2980353.